BBC vs. BBH
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and BBH (VanEck Vectors Biotech ETF) are both Health & Biotech Equities funds - BBC tracks the LifeSci Biotechnology Clinical Trials Index while BBH tracks the MVIS US Listed Biotech 25 Index. Both are passively managed. Over the past 10 years, BBC returned 10.98%/yr vs 7.19%/yr for BBH. A 0.72 correlation means they provide meaningful diversification when combined. BBC charges 0.79%/yr vs 0.35%/yr for BBH.
Performance
BBC vs. BBH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 23.79% return, which is significantly higher than BBH's 0.06% return. Over the past 10 years, BBC has outperformed BBH with an annualized return of 10.98%, while BBH has yielded a comparatively lower 7.19% annualized return.
BBC
- 1D
- 4.97%
- 1M
- 11.76%
- YTD
- 23.79%
- 6M
- 18.79%
- 1Y
- 151.23%
- 3Y*
- 26.34%
- 5Y*
- -0.15%
- 10Y*
- 10.98%
BBH
- 1D
- 0.92%
- 1M
- 2.50%
- YTD
- 0.06%
- 6M
- -1.66%
- 1Y
- 24.78%
- 3Y*
- 7.06%
- 5Y*
- -0.40%
- 10Y*
- 7.19%
BBC vs. BBH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 23.79% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
BBH VanEck Vectors Biotech ETF | 0.06% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
Correlation
The correlation between BBC and BBH is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.59 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.63 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.68 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.70 |
Correlation (All Time) Calculated using the full available price history since Dec 17, 2014 | 0.72 |
The correlation between BBC and BBH shifts across timeframes, from 0.59 (1 year) to 0.72 (all time), reflecting how their relationship changes across market environments.
BBC vs. BBH - Sectors Allocation Comparison
Sectors
BBC
BBH
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BBC
BBH
Basic Materials
BBC
-
BBH
-
Communication Services
BBC
-
BBH
-
Consumer Cyclical
BBC
-
BBH
-
Consumer Defensive
BBC
-
BBH
-
Energy
BBC
-
BBH
-
Financial Services
BBC
-
BBH
-
Industrials
BBC
-
BBH
-
Real Estate
BBC
-
BBH
-
Technology
BBC
-
BBH
-
Utilities
BBC
-
BBH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. BBH — Risk / Return Rank
BBC
BBH
BBC vs. BBH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBC | BBH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.91 | ||
| Sortino ratioReturn per unit of downside risk | +2.66 | ||
| Omega ratioGain probability vs. loss probability | 1.55 | 1.23 | +0.32 |
| Calmar ratioReturn relative to maximum drawdown | 10.08 | 2.36 | +7.72 |
| Martin ratioReturn relative to average drawdown | 29.53 | 5.69 | +23.84 |
Loading charts...
Drawdowns
BBC vs. BBH - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than BBH's maximum drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for BBC and BBH.
Loading charts...
Drawdown Indicators
| BBC | BBH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -72.70% | -4.15% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -10.55% | -4.55% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -22.74% | -31.71% |
Max Drawdown (5Y)Largest decline over 5 years | -71.97% | -39.86% | -32.11% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | -39.86% | -36.99% |
Current DrawdownCurrent decline from peak | -20.54% | -12.14% | -8.40% |
Average DrawdownAverage peak-to-trough decline | -37.09% | -20.73% | -16.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 4.36% | +0.78% |
Volatility
BBC vs. BBH - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 12.13% compared to VanEck Vectors Biotech ETF (BBH) at 6.13%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | BBH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.13% | 6.13% | +6.00% |
Volatility (6M)Calculated over the trailing 6-month period | 26.75% | 14.61% | +12.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.33% | 19.33% | +17.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.51% | 21.44% | +18.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.79% | 22.17% | +15.62% |
BBC vs. BBH - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than BBH's 0.35% expense ratio.
Dividends
BBC vs. BBH - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.37%, more than BBH's 0.51% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.37% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
Frequently Asked Questions
BBC and BBH have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (12.13%) compared to BBH (6.13%). In terms of maximum drawdown, BBC dropped -76.85% vs BBH's -72.70%.
On 10-year performance, BBC leads with 10.98% vs 7.19% for BBH. On fees, BBH is cheaper at 0.35% per year. On volatility, BBH has been the lower-risk option at 6.13%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, BBC has performed better with a 10.98% return vs 7.19%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BBH is cheaper with a 0.35% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.37%, compared with 0.51% for BBH.
BBC tracks LifeSci Biotechnology Clinical Trials Index, while BBH tracks MVIS US Listed Biotech 25 Index. They also come from different issuers: Virtus Investment Partners and VanEck. Their fees differ too: 0.79% for BBC and 0.35% for BBH.
BBC currently has the higher Sharpe Ratio (4.20 vs 1.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and BBH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer